Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Low Back Pain × Inosine Monophosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Leukemia, Myeloid, Acute 2 Osteoarthritis 1 Lymphoma, B-Cell 1 Low Back Pain 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Neoplasms 1 Cancer Pain 1

Interventions

Manipulation, Spinal 1 Inosine Monophosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03031938 2021-06-25

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Pfizer

Phase 3 Completed

4 enrolled 78 charts

Cancer Pain, Osteoarthritis, Low Back Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡